Fluorescence Biomodulation for Canine Interdigital Furunculosis: Updates for Once-Weekly Schedule

Area of Science:

• Veterinary Dermatology
• Photomedicine
• Canine Inflammatory Diseases

Background:

• Interdigital furunculosis is a prevalent, multifactorial inflammatory condition in dogs, frequently complicated by secondary bacterial infections.
• Fluorescence biomodulation (FBM) has demonstrated efficacy as an adjunctive therapy to systemic antibiotics for managing canine interdigital pyoderma, typically with a twice-weekly application schedule.

Purpose of the Study:

• To assess the clinical effectiveness of a reduced, once-weekly FBM application regimen in combination with systemic antibiotics for treating canine interdigital pyoderma.
• To compare the outcomes of once-weekly FBM therapy against established twice-weekly protocols and literature data.

Main Methods:

• Twelve dogs diagnosed with interdigital pyoderma were treated with systemic antibiotics and once-weekly FBM applications.
• Clinical improvement was monitored using a global lesion score and a neutrophil engulfing bacterial score until complete healing was achieved.

Main Results:

• The once-weekly FBM application, alongside systemic antibiotics, demonstrated comparable therapeutic benefits to the conventional twice-weekly regimen.
• The study indicated that the reduced frequency of FBM application is well-tolerated by canine patients.

Conclusions:

• A once-weekly application of FBM in conjunction with systemic antibiotics provides a similarly effective treatment for canine interdigital furunculosis as twice-weekly applications.
• This finding suggests that a less frequent FBM regimen can be a viable, potentially more cost-effective, therapeutic option for managing canine interdigital pyoderma.